Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Eye Drops for Vernal Keratoconjunctivitis
NCT07138742Not yet recruiting
- Sponsor
- Sohag University
- Start
- Sep 2025
- Primary completion
- Mar 2027
- Modality
- RNA-Targeting Small Molecules
01
Overview
Randomised, open-label trial of tacrolimus in Vernal Keratoconjunctivitis (VKC) (3 arms), sponsored by Sohag University. Primary endpoints: Total subjective symptoms score at 1 month, Total objective ocular signs score at 1 month and 2 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT07138742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07138742.